Biological
Fecal Transplant
Fecal Transplant is a biological therapy with 6 clinical trials. Historical success rate of 75.0%.
Total Trials
6
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)
Phase Distribution
Ph not_applicable
3
50%
Ph phase_1
1
17%
Ph phase_2
2
33%
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
N/ANon-phased studies
3(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(3)
Terminated(1)
Other(1)
Detailed Status
Completed3
Not yet recruiting1
unknown1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
75.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (16.7%)
Phase 22 (33.3%)
N/A3 (50.0%)
Trials by Status
not_yet_recruiting117%
unknown117%
terminated117%
completed350%
Recent Activity
0 active trials
Showing 5 of 6
not_yet_recruitingnot_applicable
NEwborn Infant of a Mother With Obesity - Fecal Microbiome Transplantation, RCT
NCT06282952
completedphase_1
Fecal Transplant in Recurrent Hepatic Encephalopathy
NCT02636647
unknownnot_applicable
Fecal Transplant for Alopecia Areata
NCT04833179
completednot_applicable
Cesarean Section and Intestinal Flora of the Newborn
NCT03568734
completedphase_2
Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis
NCT01545908
Clinical Trials (6)
Showing 6 of 6 trials
NCT06282952Not Applicable
NEwborn Infant of a Mother With Obesity - Fecal Microbiome Transplantation, RCT
NCT02636647Phase 1
Fecal Transplant in Recurrent Hepatic Encephalopathy
NCT04833179Not Applicable
Fecal Transplant for Alopecia Areata
NCT03568734Not Applicable
Cesarean Section and Intestinal Flora of the Newborn
NCT01545908Phase 2
Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis
NCT01226992Phase 2
Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin
All 6 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 6